Overview

Efficacy Study of Canakinumab to Treat Urticaria

Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
Evaluation whether canakinumab leads to improvement of urticaria
Phase:
Phase 2
Details
Lead Sponsor:
University of Zurich
Treatments:
Antibodies, Monoclonal